logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 5
  • 1
    Anthony Clarke
    Born in November 1955
    Individual (9 offsprings)
    Person with significant control
    2016-04-06 ~ 2017-08-01
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Stewart, Richard Alistair Balfour
    Born in September 1958
    Individual (17 offsprings)
    Officer
    2008-11-17 ~ now
    OF - Director → CIF 0
    Richard Alistair Balfour Stewart
    Born in September 1958
    Individual (17 offsprings)
    Person with significant control
    2016-04-06 ~ 2017-08-01
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 3
    Wan, Jerry
    Born in February 1982
    Individual (1 offspring)
    Officer
    2024-08-21 ~ now
    OF - Director → CIF 0
  • 4
    Bencich, John Allan
    Director born in April 1977
    Individual (1 offspring)
    Officer
    2020-09-10 ~ 2024-08-21
    OF - Director → CIF 0
  • 5
    Suite 2250, 520 Pike Street, Seattle, Washington, United States
    Corporate (1 offspring)
    Person with significant control
    2017-08-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
parent relation
Company in focus

ACHIEVE PHARMA UK LIMITED

Period: 2016-01-28 ~ now
Company number: 06751116
Registered names
ACHIEVE PHARMA UK LIMITED - now
Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Administrative Expenses
-2,620,565 GBP2023-01-01 ~ 2023-12-31
-1,260,466 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
-534,801 GBP2023-01-01 ~ 2023-12-31
-89,213 GBP2022-01-01 ~ 2022-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
0 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-534,801 GBP2023-01-01 ~ 2023-12-31
-89,213 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment
5,264 GBP2023-12-31
2,007 GBP2022-12-31
Debtors
663,198 GBP2023-12-31
968,745 GBP2022-12-31
Cash at bank and in hand
159,407 GBP2023-12-31
101,184 GBP2022-12-31
Current Assets
822,605 GBP2023-12-31
1,069,929 GBP2022-12-31
Net Current Assets/Liabilities
-53,625 GBP2023-12-31
484,433 GBP2022-12-31
Total Assets Less Current Liabilities
-48,361 GBP2023-12-31
486,440 GBP2022-12-31
Equity
Called up share capital
3,339,061 GBP2023-12-31
3,339,061 GBP2022-12-31
3,339,061 GBP2021-12-31
Retained earnings (accumulated losses)
-3,387,422 GBP2023-12-31
-2,852,621 GBP2022-12-31
-2,763,408 GBP2021-12-31
Equity
-48,361 GBP2023-12-31
486,440 GBP2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
-534,801 GBP2023-01-01 ~ 2023-12-31
-89,213 GBP2022-01-01 ~ 2022-12-31
Average Number of Employees
52023-01-01 ~ 2023-12-31
42022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Other
6,765 GBP2023-12-31
6,671 GBP2022-12-31
Property, Plant & Equipment - Other Disposals
Other
-4,383 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
1,501 GBP2023-12-31
4,664 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
1,220 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Other
-4,383 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Other
5,264 GBP2023-12-31
2,007 GBP2022-12-31
Amounts Owed By Related Parties
643,675 GBP2023-12-31
Current
949,921 GBP2022-12-31
Other Debtors
Amounts falling due within one year
19,523 GBP2023-12-31
18,824 GBP2022-12-31
Debtors
Amounts falling due within one year, Current
663,198 GBP2023-12-31
968,745 GBP2022-12-31
Trade Creditors/Trade Payables
Current
3,803 GBP2023-12-31
8,897 GBP2022-12-31
Amounts owed to group undertakings
Current
302,373 GBP2023-12-31
210,150 GBP2022-12-31
Other Taxation & Social Security Payable
Current
47,565 GBP2023-12-31
27,994 GBP2022-12-31
Other Creditors
Current
522,489 GBP2023-12-31
338,455 GBP2022-12-31
  • ACHIEVE PHARMA UK LIMITED
    Info
    EXTAB PHARMA LIMITED - 2016-01-28
    ABTEX PHARMA LIMITED - 2016-01-28
    Registered number 06751116
    10 Station Road, Henley-on-thames, Oxfordshire RG9 1AY
    PRIVATE LIMITED COMPANY incorporated on 2008-11-17 (17 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-17
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.